Statins and telomere length: risk assessment and management for coronary heart disease

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.7, 2007-07, pp. : 979-982

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The protective effect of pravastatin against coronary heart disease is modified by the leucocyte telomere length of the individual patient

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

By Jean-Pierre Després Isabelle Lemieux

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2177-2198

Adis International

Access to resources Recommend Favorite

The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women

Current Pharmaceutical Design, Vol. 15, Iss. 10, 2009-04 ,pp. : 1054-1062

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Uric Acid and Risk of Coronary Heart Disease

Current Pharmaceutical Design, Vol. 11, Iss. 32, 2005-12 ,pp. : 4125-4132

Bentham Science Publishers

Access to resources Recommend Favorite

Should We Encourage Over-The-Counter Statins?: A Population Perspective for Coronary Heart Disease Prevention

By Gemmell Islay

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 299-302

Adis International

Access to resources Recommend Favorite